Microba Life Sciences Ltd (MAP)

Currency in AUD
0.09
0.00(0.00%)
Closed·
MAP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
0.090.10
52 wk Range
0.080.33
Key Statistics
Bid/Ask
0.09 / 0.10
Prev. Close
0.09
Open
0.1
Day's Range
0.09-0.1
52 wk Range
0.08-0.33
Volume
746.94K
Average Volume (3m)
313.24K
1-Year Change
-45.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.24
Upside
+170.37%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Microba Life Sciences Ltd Company Profile

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.

Compare MAP to Peers and Sector

Metrics to compare
MAP
Peers
Sector
Relationship
P/E Ratio
−3.3x25.7x−0.5x
PEG Ratio
−0.08−0.030.00
Price/Book
1.3x2.2x2.6x
Price / LTM Sales
2.7x1.4x3.3x
Upside (Analyst Target)
188.9%14.7%45.4%
Fair Value Upside
Unlock14.1%7.7%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.24
(+170.37% Upside)

Earnings

Latest Release
Apr 17, 2025
EPS / Forecast
-- / --
Revenue / Forecast
3.40M / --
EPS Revisions
Last 90 days

MAP Income Statement

FAQ

What Stock Exchange Does Microba Life Sciences Trade On?

Microba Life Sciences is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Microba Life Sciences?

The stock symbol for Microba Life Sciences is "MAP."

What Is the Microba Life Sciences Market Cap?

As of today, Microba Life Sciences market cap is 45.84M.

What Is Microba Life Sciences's Earnings Per Share (TTM)?

The Microba Life Sciences EPS (TTM) is -0.03.

When Is the Next Microba Life Sciences Earnings Date?

Microba Life Sciences will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is MAP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Microba Life Sciences Stock Split?

Microba Life Sciences has split 0 times.

How Many Employees Does Microba Life Sciences Have?

Microba Life Sciences has 0 employees.

What is the current trading status of Microba Life Sciences (MAP)?

As of 03 Aug 2025, Microba Life Sciences (MAP) is trading at a price of 0.09, with a previous close of 0.09. The stock has fluctuated within a day range of 0.09 to 0.10, while its 52-week range spans from 0.08 to 0.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.